REGENXBIO
RGNX
A$12.91
Share price
-4.32%
Change (1 day)
-41.17%
Change (1 year)
Categories
REGENXBIO (RGNX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : A$0.33 Billion
According to REGENXBIO's latest financial reports the company's total liabilities are A$0.33 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
REGENXBIO - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | A$0.33 B | -13.81% |
| 2023-12-31 | A$0.38 B | -17.39% |
| 2022-12-31 | A$0.46 B | -3.38% |
| 2021-12-31 | A$0.48 B | 12.22% |
| 2020-12-31 | A$0.42 B | 530.57% |
| 2019-12-31 | A$68.14 M | 37.29% |
| 2018-12-31 | A$49.63 M | 147.63% |
| 2017-12-31 | A$20.04 M | 31.4% |
| 2016-12-31 | A$15.25 M | 143.04% |
| 2015-12-31 | A$6.27 M | -44.1% |
| 2014-12-31 | A$11.22 M | 115.24% |
| 2013-12-31 | A$5.21 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | A$35.47 M | -89.33% | 🇺🇸 USA |